Bioinformatic analysis of pathogenic missense mutations of activin receptor like kinase 1 ectodomain.
Activin A receptor, type II-like kinase 1 (also called ALK1), is a serine-threonine kinase predominantly expressed on endothelial cells surface. Mutations in its ACVRL1 encoding gene (12q11-14) cause type 2 Hereditary Haemorrhagic Telangiectasia (HHT2), an autosomal dominant multisystem vascular dysplasia. The study of the structural effects of mutations is crucial to understand their pathogenic mechanism. However, while an X-ray structure of ALK1 intracellular domain has recently become available (PDB ID: 3MY0), structure determination of ALK1 ectodomain (ALK1(EC)) has been elusive so far. We here describe the building of a homology model for ALK1(EC), followed by an extensive bioinformatic analysis, based on a set of 38 methods, of the effect of missense mutations at the sequence and structural level. ALK1(EC) potential interaction mode with its ligand BMP9 was then predicted combining modelling and docking data. The calculated model of the ALK1(EC) allowed mapping and a preliminary characterization of HHT2 associated mutations. Major structural changes and loss of stability of the protein were predicted for several mutations, while others were found to interfere mainly with binding to BMP9 or other interactors, like Endoglin (CD105), whose encoding ENG gene (9q34) mutations are known to cause type 1 HHT. This study gives a preliminary insight into the potential structure of ALK1(EC) and into the structural effects of HHT2 associated mutations, which can be useful to predict the potential effect of each single mutation, to devise new biological experiments and to interpret the biological significance of new mutations, private mutations, or non-synonymous polymorphisms.
Department of Experimental Medicine, Section of General Pathology, University of Pavia, Pavia, Italy. claudia.scotti@unipv.it
Claudia
C
Scotti
Carla
C
Olivieri
Laura
L
Boeri
Cecilia
C
Canzonieri
Federica
F
Ornati
Elisabetta
E
Buscarini
Fabio
F
Pagella
Cesare
C
Danesino
D030301:Activin Receptors, Type II / Q000737:chemistry* / Q000235:genetics* / Q000378:metabolism; D000595:Amino Acid Sequence; D019295:Computational Biology; D017124:Conserved Sequence; D004252:DNA Mutational Analysis; D004795:Enzyme Stability; D055427:Growth Differentiation Factor 2; D055412:Growth Differentiation Factors / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D020125:Mutation, Missense; D017434:Protein Structure, Tertiary; D017386:Sequence Homology, Amino Acid; D055672:Static Electricity; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000201:enzymology / Q000235:genetics / Q000473:pathology
C525887:GDF2 protein, human; D055427:Growth Differentiation Factor 2; D055412:Growth Differentiation Factors; C425364:ACVRL1 protein, human; D030301:Activin Receptors, Type II